|
|
| EVEREST: Effects of Vasopressin Receptor Antagonism With Tolvaptan on Clinical Status, Morbidity, and Mortality in Patie |
EVEREST: Effects of Vasopressin Receptor Antagonism With Tolvaptan on Clinical Status,
Morbidity, and Mortality in Patients Hospitalized With Acute Decompensated Heart Failure
by Marvin Konstam, MD
Sponsorship for the booth and interviews at ACC 2007 was provided by the Center for Health
Education (CHE) through unrestricted joint educational grants from the Medicines Company,
Merck, Schering-Plough and Scios.
[ Download video ] |
|
No comments have been submitted
|